HYPD
HYPERION DEFI, INC.
Key Financials
Net Income
$-45314435
↑ 9.0%
Operating Income
$-46721061
↑ 4.1%
Gross Profit
$510165
↑ 113.2%
Total Liabilities
$10.7M
↓ 36.1%
Revenue
$813455
↑ 1318.8%
Total Assets
$51.8M
↑ 1311.3%
EPS (Diluted)
$-9.40
↑ 84.3%
Cash & Equivalents
$6.4M
↑ 203.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14A | 4/17/2026 | View on SEC |
| 4 | 4/1/2026 | View on SEC |
| SCHEDULE 13G/A | 4/1/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/26/2026 | View on SEC |
| SCHEDULE 13G/A | 3/3/2026 | View on SEC |
| SCHEDULE 13G/A | 2/11/2026 | View on SEC |
| SCHEDULE 13G/A | 2/5/2026 | View on SEC |
| 4 | 1/12/2026 | View on SEC |
| 3 | 1/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HYPD |
| Company Name | HYPERION DEFI, INC. |
| CIK | 1682639 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 833-393-6684 |